Dr Groussin will discuss how the Global Microbiome Conservancy is working to address gaps in microbiome research by collecting, culturing, and sequencing microbial communities from a large global cohort of human populations that have highly differentiated genetic backgrounds, diets, and lifestyles. He will highlight how this effort contributes to a more inclusive and accurate picture of microbial diversity, evolution, and function. In parallel, he will introduce his ERC-funded research on the gut vesiculome (the vast array of extracellular vesicles produced by bacteria that enable inter-microbial communication and influence host physiology). Together, these projects shed light on how bacterial communities adapt, share genes, and interact with their environment, offering new opportunities for understanding microbial evolution and developing microbiome-based therapies.

Christian-Albrechts-University of Kiel & University Hospital Schleswig-Holstein

Christian-Albrechts-University of Kiel & University Hospital Schleswig-Holstein
Mathieu Groussin is Professor in the Genetics and Bioinformatics department at the Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel and University Hospital Schleswig-Holstein, Germany. His research focuses on developing advanced computational and experimental tools to study host–microbiome systems, examining how bacterial genomes and functions differ across health, disease, and a range of human lifestyles, from industrialised to traditional societies. He is co-founder of the Global Microbiome Conservancy, a global initiative to ethically collect, culture, and sequence microbiomes from under-represented human populations, helping to address long-standing gaps in microbiome research and ensure a more equitable understanding of microbial diversity.
Professor Groussin recently received a European Research Council Consolidator Grant to investigate the gut vesiculome—the wide array of extracellular vesicles produced by bacteria that facilitate microbial communication, gene exchange, and interaction with host immunity. His work brings together evolutionary biology, global health, and big data to explore how microbiome science can inform future diagnostics and therapeutics.